Genomic Diagnostics Laboratory

Molecular Pathology

GDL is a leading centre for the provision of specialised molecular pathology testing for solid tumours enabling appropriate stratification of patients for individualised treatment. Current services include EGFR and ALK testing in lung cancer (NSCLC) KRAS testing in colorectal cancer and BRAF testing in malignant melanoma.

A range of tests are also available to support research and enrolment in clinical trials including comprehensive oncogene panel tumour profiles delivered using Sequenom MassArrayTM technology and targeted tests for mutations in PIK3CA and NRAS.

Links

RSS Feed

MCGMnewsandevents

Read More...

2015-08-28
Willink Biochemical Genetics User Survey 2015

Read More...

2015-01-01
Saint Mary’s Hospital set to deliver world-leading genomics project in fight against cancer and rare diseases